Powervision

  • Alcon announces the acquisition of PowerVision

    by - Mar 19, 2019
    Alcon, a division of Novartis, announced that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating...
Contact News Hour

Facebook

Twitter